Risheng Que

1.4k total citations
45 papers, 951 citations indexed

About

Risheng Que is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Risheng Que has authored 45 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Risheng Que's work include Pancreatic and Hepatic Oncology Research (22 papers), Cancer Genomics and Diagnostics (12 papers) and Renal cell carcinoma treatment (10 papers). Risheng Que is often cited by papers focused on Pancreatic and Hepatic Oncology Research (22 papers), Cancer Genomics and Diagnostics (12 papers) and Renal cell carcinoma treatment (10 papers). Risheng Que collaborates with scholars based in China, United States and Hong Kong. Risheng Que's co-authors include Guoping Ding, Liping Cao, Jionghuang Chen, Shunliang Gao, Tingbo Liang, Xiang Li, Liping Cao, Xueli Bai, Tao Ma and Jianying Lou and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Cancer Letters.

In The Last Decade

Risheng Que

44 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Risheng Que China 16 454 435 393 214 187 45 951
Wenhe Zhao China 15 325 0.7× 218 0.5× 387 1.0× 105 0.5× 168 0.9× 45 886
Qi‐Man Sun China 18 397 0.9× 298 0.7× 470 1.2× 151 0.7× 202 1.1× 37 1.0k
Kazumasa Komura Japan 20 390 0.9× 296 0.7× 525 1.3× 380 1.8× 287 1.5× 95 1.2k
Hangcheng Zhou China 15 212 0.5× 307 0.7× 297 0.8× 163 0.8× 193 1.0× 37 740
Diana L. Hanna United States 17 258 0.6× 600 1.4× 238 0.6× 250 1.2× 164 0.9× 75 1.0k
Hongyu Zhang China 16 213 0.5× 334 0.8× 301 0.8× 149 0.7× 100 0.5× 42 842
Fuminori Sonohara Japan 17 264 0.6× 448 1.0× 378 1.0× 227 1.1× 301 1.6× 64 960
Niels Henrik Holländer Denmark 13 383 0.8× 481 1.1× 314 0.8× 119 0.6× 157 0.8× 44 838
Yuko Sugiyama Japan 14 153 0.3× 346 0.8× 244 0.6× 127 0.6× 195 1.0× 62 968
Wenzhuo He China 19 325 0.7× 878 2.0× 241 0.6× 279 1.3× 296 1.6× 84 1.3k

Countries citing papers authored by Risheng Que

Since Specialization
Citations

This map shows the geographic impact of Risheng Que's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risheng Que with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risheng Que more than expected).

Fields of papers citing papers by Risheng Que

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Risheng Que. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risheng Que. The network helps show where Risheng Que may publish in the future.

Co-authorship network of co-authors of Risheng Que

This figure shows the co-authorship network connecting the top 25 collaborators of Risheng Que. A scholar is included among the top collaborators of Risheng Que based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Risheng Que. Risheng Que is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Xueli, Xiang Li, Guoliang Qiao, et al.. (2025). Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial. Cancer Cell. 43(12). 2259–2267.e2.
2.
Chen, Yiwen, Wendi Hu, Xiang Li, et al.. (2024). Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II study. Signal Transduction and Targeted Therapy. 9(1). 280–280. 6 indexed citations
3.
Shen, Yan, Jian Wu, Shunliang Gao, et al.. (2024). Adjuvant therapy with donafenib plus anti–PD-1 antibody for patients (pts) with hepatocellular carcinoma (HCC) at high risk of recurrence after resection (PATH study).. Journal of Clinical Oncology. 42(16_suppl). e16228–e16228. 1 indexed citations
4.
Guo, Chengxiang, Jianpeng Sheng, Xing Huang, et al.. (2023). Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial. Hepatology Communications. 7(3). e0054–e0054. 12 indexed citations
5.
Yao, Zhuo, et al.. (2023). A tumor microenvironment-stimuli responsive nano-prodrug for overcoming gemcitabine chemoresistance by co-delivered miRNA-21 modulator. Biomedical Materials. 18(3). 35010–35010. 7 indexed citations
6.
Fu, Qihan, Yiwen Chen, Chengxiang Guo, et al.. (2023). Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial. Annals of Surgical Oncology. 30(8). 5071–5080. 16 indexed citations
7.
Chen, Yiwen, Jian Xu, Xiang Li, et al.. (2022). Central pancreatectomy for benign or low-grade malignant pancreatic tumors in the neck and body of the pancreas. World Journal of Gastrointestinal Surgery. 14(9). 896–903. 3 indexed citations
8.
Zhang, Qi, Mao Ye, Wei Su, et al.. (2020). Sphincter of Oddi laxity alters bile duct microbiota and contributes to the recurrence of choledocholithiasis. Annals of Translational Medicine. 8(21). 1383–1383. 15 indexed citations
9.
Chen, Wei, Dipesh Kumar Yadav, Xueli Bai, et al.. (2019). Liver Transplantation from Voluntary Organ Donor System in China: A Comparison between DBD and DCD Liver Transplants. Gastroenterology Research and Practice. 2019. 1–7. 6 indexed citations
10.
Bai, Xueli, Shunliang Gao, Jianying Lou, et al.. (2019). Role of Collateral Venous Circulation in Prevention of Sinistral Portal Hypertension After Superior Mesenteric-Portal Vein Confluence Resection during Pancreaticoduodenectomy: a Single-Center Experience. Journal of Gastrointestinal Surgery. 24(9). 2054–2061. 5 indexed citations
11.
Wei, Tao, Qi Zhang, Xiang Li, et al.. (2018). Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer. Molecular Cancer Therapeutics. 18(1). 196–203. 70 indexed citations
12.
Shen, Yinan, Xueli Bai, Gang Jin, et al.. (2018). A preoperative nomogram predicts prognosis of up front resectable patients with pancreatic head cancer and suspected venous invasion. HPB. 20(11). 1034–1043. 12 indexed citations
13.
Li, Xiang, Tao Ma, Risheng Que, et al.. (2017). Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population. Cancer Letters. 406. 22–26. 46 indexed citations
14.
Que, Risheng, Lin Cheng, Guoping Ding, Zhengrong Wu, & Liping Cao. (2016). Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer. Journal of Zhejiang University SCIENCE B. 17(5). 352–360. 67 indexed citations
15.
Shi, Xiaoyu, Risheng Que, Baoqing Liu, et al.. (2015). Role of IL-21 signaling pathway in transplant-related biology. Transplantation Reviews. 30(1). 27–30. 15 indexed citations
16.
Zhang, Weidong, et al.. (2014). Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literature. Journal of Zhejiang University SCIENCE B. 15(12). 1081–1087. 3 indexed citations
17.
Que, Risheng, Guoping Ding, Jionghuang Chen, & Liping Cao. (2013). Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World Journal of Surgical Oncology. 11(1). 219–219. 227 indexed citations
18.
Cao, Liping, et al.. (2011). Transumbilical single-port laparoscopic cholecystectomy using traditional laparoscopic instruments: a report of thirty-six cases. Journal of Zhejiang University SCIENCE B. 12(10). 862–866. 5 indexed citations
19.
20.
Liu, Daren, Liping Cao, Jiekai Yu, et al.. (2008). Diagnosis of Pancreatic Adenocarcinoma Using Protein Chip Technology. Pancreatology. 9(1-2). 127–135. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenhe Zhao Breakdown of academic impact, for papers by Qi‐Man Sun Breakdown of academic impact, for papers by Kazumasa Komura Breakdown of academic impact, for papers by Hangcheng Zhou Breakdown of academic impact, for papers by Diana L. Hanna Breakdown of academic impact, for papers by Hongyu Zhang Breakdown of academic impact, for papers by Fuminori Sonohara Breakdown of academic impact, for papers by Niels Henrik Holländer Breakdown of academic impact, for papers by Yuko Sugiyama Breakdown of academic impact, for papers by Wenzhuo He
Rankless by CCL
2026